TESARO Inc (NASDAQ:TSRO)

46.49
Delayed Data
As of 4:00pm ET
 +6.50 / +16.25%
Today’s Change
38.40
Today|||52-Week Range
153.98
-43.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.7B

Company Description

TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Contact Information

TESARO, Inc.
1000 Winter Street
Waltham Massachusetts 02451
P:(339) 970-0900
Investor Relations:
(781) 325-1116

Employees

Shareholders

Mutual fund holders59.04%
Other institutional36.82%
Individual stakeholders30.46%

Top Executives

Lonnie MoulderChief Executive Officer & Director
Mary Lynne HedleyPresident, Chief Operating Officer & Director
Timothy R. PearsonChief Financial & Accounting Officer, Executive VP
Jeffrey H. HankeChief Scientific Officer, Executive VP-R&D
Martin H. HuberChief Medical Officer & Senior Vice President